{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:40:42Z","timestamp":1787010042003,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In 2022, the World Health Organization (WHO) adapted its pediatric tuberculosis disease (TBD) treatment guidelines, recommending a shortened 4-month treatment regimen for nonsevere TB, based on a single study in high TB prevalence, low-resource settings. This study investigated to what extent the recommendations apply to a high-resource setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Retrospective cohort study of patients with TBD &lt;16 years of age treated at the Austrian Reference Centre for Paediatric TB from 2010 to 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      One hundred fifty-nine patients were included in the final analysis. Based on the WHO guidelines, 104 (65.4%) met the criteria for nonsevere TBD. Compared with children with severe TBD (n = 55; 34.6%), children with nonsevere TBD were significantly more commonly asymptomatic (26.0% vs. 83.6%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2264 0.0001), more commonly detected by TB screening (14.6% vs. 74.0%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2264 0.0001) and less commonly microbiologically-confirmed (36.5% vs. 85.5%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2264 0.0001). Eight children categorized as nonsevere had evidence of severe disease on chest computed tomography; 9 had evidence of severe disease on bronchoscopy. Nineteen children in the nonsevere group had positive polymerase chain reaction results for\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      complex. Taking computed tomography, bronchoscopy and polymerase chain reaction results into account, 28 (26.9%) of the 104 cases initially classified as nonsevere would have to be reclassified as severe (equating to a 50.9% increase in the severe group). Consequently, only 76 (47.8%) patients would ultimately qualify as nonsevere TBD, while 83 (52.2%) had severe TBD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our results suggest there is a substantial risk of underestimating disease severity when using the WHO criteria in isolation. Incorrect classification of disease severity may result in insufficient treatment and potentially treatment failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005081","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T14:00:10Z","timestamp":1764684010000},"page":"399-404","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Potential Limitations of the World Health Organization Criteria for Nonsevere Tuberculosis in Children in a Low Prevalence, High-resource Setting"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1004-8970","authenticated-orcid":false,"given":"Yasmin","family":"Heimbach-Weber","sequence":"first","affiliation":[{"name":"Department of Pediatric and Adolescent Medicine, Austrian Reference Centre for Paediatric Tuberculosis, Klinik Ottakring, Vienna Healthcare Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Langthaler","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Medicine, Austrian Reference Centre for Paediatric Tuberculosis, Klinik Ottakring, Vienna Healthcare Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bogyi","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Medicine, Austrian Reference Centre for Paediatric Tuberculosis, Klinik Ottakring, Vienna Healthcare Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vira","family":"Chechenieva","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Medicine, Austrian Reference Centre for Paediatric Tuberculosis, Klinik Ottakring, Vienna Healthcare Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rothensteiner","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Medicine, Austrian Reference Centre for Paediatric Tuberculosis, Klinik Ottakring, Vienna Healthcare Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Baier-Grabner","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Medicine, Austrian Reference Centre for Paediatric Tuberculosis, Klinik Ottakring, Vienna Healthcare Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Zacharasiewicz","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Medicine, Austrian Reference Centre for Paediatric Tuberculosis, Klinik Ottakring, Vienna Healthcare Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Heger","sequence":"additional","affiliation":[{"name":"National Reference Laboratory for Tuberculosis, Austrian Agency for Health and Food Safety (AGES)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Indra","sequence":"additional","affiliation":[{"name":"National Reference Laboratory for Tuberculosis, Austrian Agency for Health and Food Safety (AGES)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Tebruegge","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Medicine, Austrian Reference Centre for Paediatric Tuberculosis, Klinik Ottakring, Vienna Healthcare Group"},{"name":"Infectious Diseases Network, Vienna Healthcare Group, Vienna, Austria"},{"name":"Department of Pediatrics, Royal Children\u2019s Hospital Melbourne, University of Melbourne, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"G\u00f6tzinger","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Medicine, Austrian Reference Centre for Paediatric Tuberculosis, Klinik Ottakring, Vienna Healthcare Group"},{"name":"Infectious Diseases Network, Vienna Healthcare Group, Vienna, Austria"},{"name":"Division of Pediatric Pulmonology, Allergy and Endocrinology, Comprehensive Center of Pediatrics, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"R1-20260410","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12098-023-04910-4","article-title":"Current epidemiology of pediatric tuberculosis.","volume":"91","author":"Mane","year":"2024","journal-title":"Indian J Pediatr"},{"key":"R2-20260410","doi-asserted-by":"crossref","first-page":"e2020032490","DOI":"10.1542\/peds.2020-032490","article-title":"Mortality in South African children and adolescents routinely treated for tuberculosis.","volume":"147","author":"Osman","year":"2021","journal-title":"Pediatrics"},{"key":"R4-20260410","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0140-6736(19)32045-8","article-title":"Challenges and controversies in childhood tuberculosis.","volume":"394","author":"Reuter","year":"2019","journal-title":"Lancet"},{"key":"R5-20260410","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"R6-20260410","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/INF.0000000000003584","article-title":"Age-specific clinical presentation and risk factors for extrapulmonary tuberculosis disease in children.","volume":"41","author":"Dubois","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20260410","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa2104535","article-title":"Shorter treatment for nonsevere tuberculosis in African and Indian children.","volume":"386","author":"Turkova","year":"2022","journal-title":"N Engl J Med"},{"key":"R10-20260410","first-page":"732","article-title":"The spectrum of disease in children treated for tuberculosis in a highly endemic area.","volume":"10","author":"Marais","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"R11-20260410","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/cid\/ciae158","article-title":"Tuberculosis disease in immunocompromised children and adolescents: a pediatric tuberculosis network European trials group multicenter case-control study.","volume":"79","author":"Rodriguez-Molino","year":"2024","journal-title":"Clin Infect Dis"},{"key":"R12-20260410","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/thorax-2022-218929","article-title":"Performance of quantiferon-TB gold plus assays in paediatric tuberculosis: a multicentre ptbnet study.","volume":"78","author":"Buonsenso","year":"2023","journal-title":"Thorax"},{"key":"R15-20260410","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cid\/ciab982","article-title":"Treatment and outcome in children with tuberculous meningitis: a multicenter pediatric tuberculosis network European trials group study.","volume":"75","author":"Thee","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R16-20260410","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/cid\/ciz1138","article-title":"Tuberculosis disease in children and adolescents on therapy with antitumor necrosis factor-a agents: a collaborative, multicenter paediatric tuberculosis network European trials group (ptbnet) study.","volume":"71","author":"Noguera-Julian","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R17-20260410","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(14)62335-7","article-title":"Shortage of purified protein derivative for tuberculosis testing.","volume":"384","author":"Tebruegge","year":"2014","journal-title":"Lancet"},{"key":"R18-20260410","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1164\/ajrccm.161.4.16141","article-title":"Diagnostic Standards and Classification of Tuberculosis in Adults and Children.","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R19-20260410","doi-asserted-by":"crossref","first-page":"1800346","DOI":"10.1183\/13993003.00346-2018","article-title":"Use of Xpert Mtb\/Rif ultra assays among paediatric tuberculosis experts in Europe.","volume":"51","author":"Villanueva","year":"2018","journal-title":"Eur Respir J"},{"key":"R21-20260410","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/archdischild-2020-321426","article-title":"Pharmacokinetics and safety\/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis.","volume":"107","author":"Ruslami","year":"2022","journal-title":"Arch Dis Child"},{"key":"R22-20260410","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1365-3156.2009.02375.x","article-title":"Toxicity of first-line drugs for treatment of tuberculosis in children: review.","volume":"14","author":"Frydenberg","year":"2009","journal-title":"Trop Med Int Health"},{"key":"R23-20260410","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/ijmy.ijmy_75_20","article-title":"Adverse drug reactions of anti-tuberculosis treatment among children with tuberculosis.","volume":"9","author":"Laghari","year":"2020","journal-title":"Int J Mycobacteriol"},{"key":"R25-20260410","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/INF.0000000000004016","article-title":"Prevalence and clinical characteristics of children with nonsevere tuberculosis in Spain.","volume":"42","author":"Hernanz-Lobo","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"R26-20260410","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1073\/pnas.062056099","article-title":"Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia.","volume":"99","author":"Delgado","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-20260410","doi-asserted-by":"crossref","first-page":"1902004","DOI":"10.1183\/13993003.02004-2019","article-title":"Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre paediatric tuberculosis network European trials group (ptbnet) study.","volume":"56","author":"Basu Roy","year":"2020","journal-title":"Eur Respir J"},{"key":"R28-20260410","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0954-6111(96)80006-0","article-title":"Skin anergy and tuberculosis.","volume":"86","author":"Maher","year":"1992","journal-title":"Respir Med"},{"key":"R29-20260410","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S1473-3099(24)00494-8","article-title":"Sequential and parallel testing for microbiological confirmation of tuberculosis disease in children in five low-income and middle-income countries: a secondary analysis of the rapaed-Tb study.","volume":"25","author":"Olbrich","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"R30-20260410","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijid.2024.01.003","article-title":"Diagnostic accuracy of Xpert Mtb\/Rif ultra for childhood tuberculosis in West Africa\u2014a multicenter pragmatic study.","volume":"140","author":"Diallo","year":"2024","journal-title":"Int J Infect Dis"}],"updated-by":[{"DOI":"10.1097\/inf.0000000000005289","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:01:40Z","timestamp":1775793700000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005081","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]}}}